|
Bladder Cancer
|
TACSTD2, EDIL-3, Mucin4, EPS8L2, α6-integrin, MUC-1, Basigin
|
Urine
|
[126]
|
|
Breast cancer
|
Survivin, Survivin-2B, CEA, Ttumor antigen15-3
|
Blood
|
[116, 118]
|
|
Colorectal cancer
|
CEA
|
Blood
| |
|
Lung cancer
|
EpCAM, EGFR, CEA, LRG-1
|
Blood
|
[100, 101, 137]
|
|
Melanoma
|
CD63, Caveolin1, TYRP2, VLA-4, HSP70
|
Blood
|
[133, 134, 139]
|
|
Nasopharyngeal cancer
|
LMP1, Galectin-9, BARF-1
|
Blood, Saliva
|
[103]
|
|
Ovarian cancer
|
Claudin-4, L1CAM, CD24, ADAM10, EMMPRIN, TGFβ1, MAGE3/6
|
Blood
|
[97, 129]
|
|
Pancreatic cancer
|
GPC1, MIF
|
Blood
|
[42, 138]
|
|
Prostate cancer
|
Transmembrane, protease, Serine2-ETS, β-catenin, PCA3, PSA, PSMA, ITGA3, ITGB1, survivin, PTEN
|
Urine
|
[127, 140]
|
|
Renal cell carcinoma
|
MMP-9, EMMPRIN, Carbonic anhydrase
|
Urine
|
[125]
|
|
Spongioblastoma
|
EGFR-VIII, EGFR, PDPN, IDH1
|
Blood
|
[123, 124, 139]
|
|
Stomach cancer
|
HER-2/neu, CCR6
|
Blood
|
[119]
|
